leisure time -WSS

leisure time

author：explore 2025-09-29 20:17:40 - browse：24

Andrew Witty, Chief Executive Officer of UnitedHealth Group, testifies at a Senate Finance Committee hearing examining cyber attacks.-- health tech coverage from STAT — UnitedHealth Group CEO Andrew Witty said the company was beginning to see a “disturbance” in its Medicaid medical costs. Jacquelyn Martin/AP

You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

What’s next for Risant?

Kaiser Permanente grabbed everyone’s attention last year when it said it was creating Risant Health, a new and vague entity that acquired Geisinger and had plans to scoop up at least four more health systems that are focused on “value-based care.”

Well, nothing has happened since then, at least publicly. Instead, everyone has been playing the parlor game of guessing who those next systems could be. There are some rumblings that the next deal could be announced in the near future. After reading some recent hospital financial reports, it’s clear there are a handful of systems that mirror Geisinger’s shaky trajectory and could find themselves in Kaiser’s crosshairs.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： The Biogen Aduhelm mess could happen again

leisure time

knowledge

WSS

Reporting on presidential health from Reagan to Trump and Biden

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Surprise medical billing ban raises prices elsewhere

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Weight loss drugs aren’t covered by Obamacare. That may change

focus

leisure time

What’s next for Risant?

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Psychedelics group wrestles with new pharma identity

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Anesthesiologist group: stop taking Ozempic before surgery

Johnson & Johnson sued for allegedly overpaying for workers' drugs

How one medical school became remarkably diverse

Congress may force more Covid

As demand for Covid shots wanes, Moderna seeks its next success

Adopting new red light myopia treatments may be short

Guidelines to prevent youth baseball injuries need more muscle

Measles policy set amid Florida outbreak alarms vaccine proponents

focus

The Biogen Aduhelm mess could happen again

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Congress may force more Covid

Congress may force more Covid

340B reform proposal comes out of Senate working group

Surprise medical billing ban raises prices elsewhere

leisure time

leisure time

knowledge

hotspot